Table 2 Treatment response rate in MDS/CMML patients after IPS
Treatment | Positive IPS (n = 10) | Negative IPS (n = 11) |
|---|---|---|
Platelet transfusion | 3/6 (50%) | 6/6 (100%) |
Steroids | 2/6 (33%) | 0/4 (0%) |
IVIG | 1/4 (25%) | 0/4 (0%) |
Dapsone | 0/2 (0%) | 0/2 (0%) |
Rituximab | 0/2 (0%) | 0/2 (0%) |
TPO-RAs | 0/1 (0%) | 0/2 (0%) |
Danatrol | 1/1 (100%) | 0/2 (0%) |
Azacitidine | 1/4 (25%) | 1/2 (50%) |